Summary:
The Diabetes Research Center is conducting a 7-month study to evaluate a once weekly anti-hyperglycemic injection for people with Type 2 Diabetes who are on either metformin only or metformin and Lantus insulin.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of Type 2 Diabetes
Qualified Participants May Receive:
Free study related diabetes care and compensation for time and travel.